Oncotelic Revenue and Competitors
Estimated Revenue & Valuation
- Oncotelic's estimated annual revenue is currently $4.2M per year.
- Oncotelic's estimated revenue per employee is $155,000
Employee Data
- Oncotelic has 27 Employees.
- Oncotelic grew their employee count by 13% last year.
Oncotelic's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | CMO | Reveal Email/Phone |
3 | Chief Clinical Officer-Translational Medicine | Reveal Email/Phone |
4 | Product Manager | Reveal Email/Phone |
Oncotelic Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Oncotelic?
Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for cancer, covid-19, and other viruses
keywords:N/A
N/A
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Agoura Hills
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.6M | 29 | 12% | N/A |
#2 | $2.9M | 29 | -9% | N/A |
#3 | $4.9M | 30 | 11% | N/A |
#4 | $2.4M | 30 | 25% | N/A |
#5 | $5.4M | 33 | 43% | N/A |